Institution scientifique

BenevolentAI (United Kingdom)

London · GB · company

168Publications signalées

44023Citations signalées

12Thèmes principaux

Principaux domaines

Computational Drug Discovery MethodsProtein Structure and DynamicsBiomedical Text Mining and OntologiesMachine Learning in Materials ScienceBioinformatics and Genomic NetworksCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchMachine Learning in BioinformaticsDiverse Scientific and Economic StudiesGenetic Associations and EpidemiologyRNA and protein synthesis mechanismsTheology and Philosophy of Evil

Évolution annuelle

1923 1

1933 1

1950 1

1952 1

1956 1

1957 1

1959 1

1960 2

1962 2

1970 1

1972 1

1974 2

1979 1

2003 1

2004 1

2008 2

2009 2

2015 1

2016 2

2017 6

2018 12

2019 19

2020 32

2021 15

2022 16

2023 15

2024 10

2025 6

Publications récentes

Accès ouvert 2025 preprintOpenAlex

Integration of artificial intelligence and high-content screening enabled identification of drugs for long-term treatment of cerebral cavernous malformation disease

Eduardo Frías-Anaya, Helios Gallego-Gutiérrez, Cassandra Bui, Janeth O. Birrueta et autres

0 citationsbioRxiv (Cold Spring Harbor Laboratory)

Accès ouvert 2025 articleOpenAlex

Discovery of a Potent, Selective, and Brain-Penetrant Checkpoint Kinase 1 Inhibitor, BEN-28010, for the Treatment of Glioblastoma

Michael J. Rawling, Arpita Ray‐Sinha, Michael Bestwick, Sandeep K. Chahal et autres

5 citationsJournal of Medicinal Chemistry

2025 preprintOpenAlex

Artificial intelligence-augmented drug discovery identifies gefitinib as a potential treatment for ALS

Monika A. Myszczynska, Matthew J. Stopford, Nóra M. Márkus, Sophie Nyberg et autres

1 citationbioRxiv (Cold Spring Harbor Laboratory)

Accès ouvert 2025 articleOpenAlex

Identification of a TNIK-CDK9 Axis as a Targetable Strategy for Platinum-Resistant Ovarian Cancer

Noah Puleo, Harini Ram, Michele L. Dziubinski, Dylan Carvette et autres

4 citationsMolecular Cancer Therapeutics

Accès ouvert 2025 conference-abstractOpenAlex

DOP098 Development of BEN8744, a phase 2 ready, peripherally restricted PDE10 inhibitor targeting a new mechanism of action for the treatment of ulcerative colitis.

J Molnár, Jane McGuffog, Ramanatha Saralaya, Nicola Robas et autres

1 citationJournal of Crohn s and Colitis

Accès ouvert 2025 conference-paperOpenAlex

Retrieve to Explain: Evidence-driven Predictions for Explainable Drug Target Identification

Ravi Patel, Angus Brayne, Rogier Hintzen, Daniel Jaroslawicz et autres

2 citations

2024 articleOpenAlex

Discovery of UCB9386: A Potent, Selective, and Brain-Penetrant Nuak1 Inhibitor Suitable for In Vivo Pharmacological Studies

Karine G. Poullennec, Eric Jnoff, Jan Abendroth, Naresh Bhuma et autres

5 citationsJournal of Medicinal Chemistry

2024 articleOpenAlex

Premier baromètre français de l’expérience patient sur la polyarthrite rhumatoïde

G. Rousson, Sonia Tropé, C. Bélorgey, J. Molésin et autres

0 citationsRevue du Rhumatisme

2024 articleOpenAlex

Process Development for the Manufacture of a Topical Pan-Trk Inhibitor Incorporating Decarboxylative sp2–sp3 Cross-Coupling

Michael S. Ashwood, Edward I. Balmond, David Fengas, Jane McGuffog et autres

1 citationOrganic Process Research & Development

Accès ouvert 2024 articleOpenAlex

Large-Scale Pharmacogenomics Analysis of Patients With Cancer Within the 100,000 Genomes Project Combining Whole-Genome Sequencing and Medical Records to Inform Clinical Practice

Ivone Leong, Claudia Cabrera, Valentina Cipriani, Paul J. Ross et autres

17 citationsJournal of Clinical Oncology

Accès ouvert 2024 articleOpenAlex

EZH2 functional dichotomy in reactive oxygen species-stratified glioblastoma

Lynnette Koh, Qing You Pang, Wisna Novera, See Wee Lim et autres

4 citationsNeuro-Oncology

Accès ouvert 2024 preprintOpenAlex

funkea: Functional Enrichment Analysis in Python

Benjamin Tenmann, Karina Close, Andrea Rodríguez Martínez, Samer Abujudeh

0 citationsbioRxiv (Cold Spring Harbor Laboratory)

Site officiel Identifiant ROR

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.